plerixafor has been researched along with HIV in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
Asaftei, S; De Clercq, E | 1 |
Bachan, S; Fantini, J; Garg, H; Joshi, A; Mootoo, DR | 1 |
Huang, B; Kang, D; Liu, N; Liu, X; Zhan, P; Zhang, H; Zhao, F | 1 |
Fujino, M; Kaneko, M; Kobayakawa, T; Murakami, T; Owusu, KB; Tamamura, H; Tsuji, K; Wang, R; Yamamoto, N | 1 |
De Clercq, E | 1 |
Borrell, JI; Clotet, B; Esté, JA; Mena, MP; Pérez-Nueno, VI; Pettersson, S; Teixidó, J | 1 |
Blauvelt, A; Borris, DL; Gulden, FO; Kawamura, T; Lederman, MM; McNamara, DT; Orenstein, JM; Sugaya, M; Zimmerman, PA | 1 |
Akashi, H; Haining, H; Hosie, MJ; Ikeda, Y; McMonagle, EL; Miyazawa, T; Shimojima, M; Takeuchi, Y; Willett, BJ | 1 |
Balzarini, J; Böhlmstedt, A; Bölmstedt, A; De Clercq, E; Hatse, S; Peumans, W; Schols, D; Van Damme, E; Van Laethem, K; Vandamme, AM; Vermeire, K | 1 |
Armand-Ugón, M; Ballana, E; Clotet, B; Clotet-Codina, I; De Marco, S; Esté, JA; Gombert, FO; Llano, A; Moncunill, G; Pauls, E; Romagnoli, B; Vrijbloed, JW | 1 |
De Clercq, E; Esté, JA; Henson, G; Schols, D | 1 |
De Clercq, E; Esté, JA; Henson, G; Schols, D; Struyf, S; Van Damme, J | 1 |
Schols, D | 1 |
Bolognesi, DP; Galasso, G; Hammer, SM; Hirsch, MS; LaBranche, CC; Moore, JP | 1 |
3 review(s) available for plerixafor and HIV
Article | Year |
---|---|
Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities.
Topics: Anti-HIV Agents; Drug Discovery; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Receptors, CXCR4; Small Molecule Libraries; Structure-Activity Relationship | 2016 |
The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).
Topics: Amino Acid Sequence; Anti-HIV Agents; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; HIV; Humans; Lymphoma, Non-Hodgkin; Molecular Sequence Data; Multiple Myeloma; Protein Conformation; Receptors, CXCR4; Virus Internalization | 2009 |
HIV fusion and its inhibition.
Topics: Anti-HIV Agents; Benzylamines; CD4 Immunoadhesins; Cyclams; Enfuvirtide; Heterocyclic Compounds; HIV; HIV Envelope Protein gp41; HIV Infections; Humans; Membrane Fusion; Peptide Fragments; Receptors, HIV | 2001 |
11 other study(ies) available for plerixafor and HIV
Article | Year |
---|---|
"Viologen" dendrimers as antiviral agents: the effect of charge number and distance.
Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Dendrimers; HIV; Humans; Static Electricity; Structure-Activity Relationship; Viologens | 2010 |
Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.
Topics: Antiviral Agents; Cell Line; Disaccharides; Drug Evaluation, Preclinical; Esters; Fatty Acids; Galactosylceramides; Glycolipids; HIV; HIV Envelope Protein gp120; HIV Infections; Humans; Micelles; Peptides; Protein Binding; Receptors, CXCR4; Structure-Activity Relationship; Surface Properties | 2011 |
Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment.
Topics: Anti-HIV Agents; Capsid Proteins; Dose-Response Relationship, Drug; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; Structure-Activity Relationship | 2020 |
Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor.
Topics: Benzylamines; Cell Line; Cyclams; Drug Design; Heterocyclic Compounds; HIV; HIV Fusion Inhibitors; Humans; Molecular Dynamics Simulation; Protein Binding; Receptors, CXCR4 | 2010 |
R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms.
Topics: Antibodies, Monoclonal; Benzylamines; CCR5 Receptor Antagonists; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Adhesion Molecules; Chemokine CCL5; Cyclams; Dendritic Cells; Endocytosis; Epithelial Cells; Female; Genetic Predisposition to Disease; Genotype; Heterocyclic Compounds; HIV; HIV Infections; Humans; Langerhans Cells; Lectins, C-Type; Male; Open Reading Frames; Polymorphism, Genetic; Receptors, CCR5; Receptors, Cell Surface; Receptors, CXCR4; Sequence Deletion; Virus Replication | 2003 |
Use of CD134 as a primary receptor by the feline immunodeficiency virus.
Topics: Amino Acid Sequence; Animals; Benzylamines; Cats; CD4-Positive T-Lymphocytes; Cell Line; Cell Line, Tumor; Cyclams; DNA, Complementary; Gene Library; HeLa Cells; Heterocyclic Compounds; HIV; Humans; Immunodeficiency Virus, Feline; Mice; Molecular Sequence Data; NIH 3T3 Cells; Receptors, CXCR4; Receptors, OX40; Receptors, Tumor Necrosis Factor; Receptors, Virus; Species Specificity; Transduction, Genetic; Transfection | 2004 |
Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.
Topics: Amino Acid Substitution; Anti-HIV Agents; Bacterial Proteins; Benzylamines; Caffeic Acids; Carrier Proteins; Cell Line; Coculture Techniques; Cyclams; Dextran Sulfate; Drug Resistance, Viral; Enfuvirtide; Giant Cells; Glycosylation; Heterocyclic Compounds; HIV; HIV Envelope Protein gp120; HIV Envelope Protein gp41; Liliaceae; Microbial Sensitivity Tests; Models, Molecular; Mutation, Missense; Peptide Fragments; Plant Lectins; Receptors, HIV; Succinates; Virus Replication | 2004 |
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Benzylamines; Calcium Signaling; Cell Death; Cell Line; Chemokine CXCL12; Chemotaxis; Cyclams; Drug Resistance, Viral; Heterocyclic Compounds; HIV; Humans; Leukocytes, Mononuclear; Lymphoid Tissue; Macrophages; Peptides, Cyclic; Receptors, CXCR4; Time Factors; Viral Envelope Proteins; Virus Replication | 2008 |
Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.
Topics: Anti-HIV Agents; Benzylamines; Cell Line; Cells, Cultured; Cyclams; GTP-Binding Proteins; Heterocyclic Compounds; HIV; Humans; Membrane Proteins; Receptors, CXCR4; Receptors, HIV; Simian Immunodeficiency Virus; Virus Replication | 1997 |
Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
Topics: Anti-HIV Agents; Antibody Specificity; Benzylamines; Binding Sites, Antibody; Binding, Competitive; Calcium; Cell Line; Chemokine CXCL12; Chemokines, CXC; Chemotaxis, Leukocyte; Cyclams; Cytokines; Dose-Response Relationship, Drug; Heterocyclic Compounds; HIV; HIV-2; Humans; Receptors, CXCR4; T-Lymphocytes | 1997 |
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Benzylamines; Cyclams; Heterocyclic Compounds; HIV; HIV Infections; Humans; Receptors, CXCR4; T-Lymphocytes | 1999 |